StockData
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc. (TYRA) stock

TYRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 7/30
$19.57−0.17 (-0.86%)

Close on Nov 17, 2026Market cap $1.17BP/E –Yield –

Tyra Biosciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Tyra Biosciences's price to book ratio was 3.5× on Nov 11, 2026, against 4.3× a year earlier. Over the last 5 years it ranged from 1.0× to 7.9×, with a median of 2.3×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20263.5×−1.5
2025Dec 31, 20255.0×+3.0
2024Dec 31, 20242.0×−0.6
2023Dec 29, 20232.7×+1.5
2022Dec 30, 20221.2×−0.7
2021Dec 31, 20211.9×–

More Tyra Biosciences figures

See a number that looks wrong?